NRO Neurones SA

NEURONES: Revenues stable (+0.2%) in 1st half of 2020

NEURONES: Revenues stable (+0.2%) in 1st half of 2020

PRESS INFORMATION                  Nanterre, August 4, 2020 (after the closing of the stock exchange)

Heading: 1st half 2020 revenues

Revenues stable (+0.2%) in 1st half of 2020

Revenues (in millions of euros)20192020growthof which organic
1st quarter128.7135.3+5.1%+5.4%
2nd quarter125.1119.1-4.9%-4.9%
Total 1st half year253.8254.4+0.2%+0.4%

Achievements

In the very special context of the second quarter, sales were ultimately better than expected.

Thanks to the good resistance of volumes, the group's business mix (significant proportion of recurring contracts, customers with little exposure overall), its organization into specialized companies and the use of the partial activity system, the operating profit for the first half year was also higher than expected: 8.7% of revenue (¹), compared to 9.1% for the first six months of 2019 (²).

As of June 30, 2020, cash net of financial debts (excluding IFRS16 rental debts) amounted to €228.9 million compared to €182.3 million a year earlier.

(¹) Unaudited and after 0.3% of expenses related to bonus shares.

(²) Excluding capital gain on disposal.

Outlook

The ongoing start-up of new recurring contracts generated an increase in personnel (net growth of 80 people in the 1st half of 2020).

Despite the uncertainties about the development of the health crisis, the intensity of the economic crisis and the probable hardening of the market, NEURONES is raising its forecasts of May 6, 2020 and now expects for the whole year:

  • revenues of at least €495 million (vs €475 million),
  • an operating profit of at least 8% (vs 6%).

In the medium term, the current crisis should have an accelerating effect on the digital transformation of organizations, which will be favorable for the group's line of services.

About NEURONES

With nearly 5,500 experts, the NEURONES group specializes in Consulting (Management, Organization and Digital) and Digital Services (Infrastructures and Applications). It supports its clients in their digital transformation projects and in the upgrading of their information systems.

Euronext Paris (compartment B - NRO) - Enternext Tech 40 - deferred settlement service for mid-cap stocks

Press Relations:

O’Connection

Floriane MONNIER

Tel: 06 32 37 57 28

 



NEURONES

Matthieu Vautier

Tel: +33 (0)1 41 37 41 37

Investor Relations:

NEURONES

Paul-César Bonnel

Tel: +33 (0)1 41 37 41 37

Attachment

EN
04/08/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurones SA

 PRESS RELEASE

NEURONES: Organic growth up 5.1% in 3rd quarter 2025

NEURONES: Organic growth up 5.1% in 3rd quarter 2025 PRESS INFORMATIONHeading: 3rd quarter 2025 revenues        Nanterre, November 5, 2025 (after trading) Organic growth up 5.1% in 3rd quarter 2025 (not audited, in millions of euros)20242025growthof which organic3rd quarter revenues196.7207.9+ 5.7%+ 5.1%Total as at the end-September599.1632.2+ 5.5%+ 4.7% Achievements In a declining French market, NEURONES has continued its momentum in the third quarter, in line with the start of the year. Growth is particularly strong in the areas of Data & AI, digital projects, ITSM (Ser...

 PRESS RELEASE

NEURONES : + 5,1% de croissance organique au 3e trimestre 2025

NEURONES : + 5,1% de croissance organique au 3e trimestre 2025 INFORMATION PRESSERubrique : C.A. 3e trimestre 2025        Nanterre, le 5 novembre 2025 (après Bourse) + 5,1% de croissance organique au 3e trimestre 2025 (non audités, en millions d’euros)20242025croissancedont organiqueChiffre d’affaires 3e trimestre196,7207,9+ 5,7%+ 5,1%Cumul à fin septembre599,1632,2+ 5,5%+ 4,7% Réalisations Dans un marché français en repli, NEURONES a poursuivi sa dynamique au 3e trimestre, dans la continuité du début de l’année. La croissance est particulièrement soutenue dans les domain...

 PRESS RELEASE

NEURONES: Declaration of transactions on treasury shares (October 13 t...

NEURONES: Declaration of transactions on treasury shares (October 13 to 17, 2025) Nanterre, October 21, 2025 Declaration of transactions on treasury shares(period from 13 to 17 October 2025) As part of the share buyback program authorized by the General Meeting of June 5, 2025, NEURONES made the following purchases between October 13 and 17, 2025 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)10/16/202510,000€38.0510/17/2025      489€38.10Total10,489  As of October 17, 2025, excluding the liquidity contract, NEURONES now holds 10,489 ...

 PRESS RELEASE

NEURONES : Déclaration des transactions sur actions propres (période ...

NEURONES : Déclaration des transactions sur actions propres (période du 13 au 17 octobre 2025) Nanterre, le 21 octobre 2025 Déclaration des transactions sur actions propres(période du 13 au 17 octobre 2025) Dans le cadre du programme de rachat d’actions propres autorisé par l’Assemblée Générale du 5 juin 2025, NEURONES a procédé, entre le 13 et le 17 octobre 2025, aux achats suivants (code ISIN FR0004050250) : JourVolume total journalier(en nombre d'actions)Prix pondéré moyen(journalier unitaire)16/10/202510 00038,05 €17/10/2025      48938,10 €Total10 489  Au 17 octobre 2025, hors contra...

 PRESS RELEASE

NEURONES : Rapport financier premier semestre 2025

NEURONES : Rapport financier premier semestre 2025 NEURONES : Rapport financier premier semestre 2025 Pièce jointe

ResearchPool Subscriptions

Get the most out of your insights

Get in touch